Aardvark Therapeutics, Inc. Financial Overview
Aardvark Therapeutics, Inc.'s market cap is currently $303.08M. The company's EPS TTM is $-0.75; its P/E ratio is -5.88; Aardvark Therapeutics, Inc. is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-0.84. See an overview of income statement, balance sheet, and cash flow financials.
